You are here: Industry Insights > CMS

News List

Healthcare providers can expect to receive US$725 reimbursement from CMS when using NGS-based Sentosa(R) SQ HIV-1 Genotyping Assay prnasia
January 10, 2022
Vela Diagnostics announced that its Sentosa® SQ HIV-1 Genotyping Assay is covered for reimbursement from The Centers for Medicare and Medicaid (CMS) starting January 2022.
Biden Reverses Trump Policy Limiting U.S. Nursing Home Fines drugs
August 02, 2021
The Biden administration has reversed a Trump policy that limited the size of fines that U.S. nursing homes could be slapped with for violating safety standards.
Medicare's Penalties for Poor-Quality Dialysis Centers Aren't Helping: Study drugs
June 10, 2021
Dialysis centers hit with financial penalties for poor performance don't tend to improve afterward, calling into question a set of U.S. federal programs intended to improve health care nationwide, a new report says.
Neuland Laboratories Q3FY21 consolidated PAT rises to Rs 26.73 crore expresspharma
February 03, 2021
The driver of this quarter's CMS uptick has been the strong performance from the scaleup projects which have contributed to the revenues.
Sun Pharma gives commercialisation license to CMS for seven products expresspharma
August 21, 2019
Sun Pharmaceutical Industries announced that one of its wholly owned subsidiaries has granted an exclusive license to a subsidiary of China Medical System Holdings (CMS) to develop and commercialise seven generic products in Mainland China.
Sun Pharma and CMS to commercialise CsA eye drops in China pharmaceutical-technology
July 01, 2019
A subsidiary of Sun Pharmaceutical Industries has signed an agreement with a China Medical System (CMS) subsidiary to develop and commercialise Cyclosporine A 0.09% (CsA) eye drops.
Sun Pharma and CMS enter into a License Agreement for Cyclosporine A and Tildrakizumab in Greater… expressbpd
June 28, 2019
Under the terms of the license agreement, CMS will pay Sun Pharma an initial upfront payment, regulatory and sales milestone payments, and royalties on net sales, the terms of which are confidential
US healthcare spending to reach $6tn by 2027 pharmaceutical-technology
February 22, 2019
Healthcare spending in the US is projected to rise at an average rate of 5.5% per year from 2018 and to reach nearly $6tn by 2027, according to a report from the Centres for Medicare & Medicaid Services (CMS).....
Medicare coverage for CAR-T drugs on the horizon pharmaphorum
February 19, 2019
Medicare could soon cover CAR-T therapies under new proposals from the US’ Centers for Medicare & Medicaid Services (CMS), which aim to also gather real-world evidence to eventually inform expanded coverage.
CMS Finalizes 2019 Medicare Clinical Lab Payment Determinations healthindustrywashingtonwatch
November 28, 2018
CMS has released its final 2019 Medicare clinical laboratory fee schedule (CLFS) payment determinations for new and reconsidered clinical lab test codes....

Previous page 1 2 Next page